The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World

The story of the biotech unicorn in the right place, at the right time, with the right technology.



At the start of 2020, Moderna was a waning biotech unicorn, still years away from delivering its first product despite a decade of development of a potentially breakthrough innovation: using RNA to combat disease. Investors were getting antsy or, worse, skeptical.



Then the coronavirus pandemic hit, and Moderna became a central player in a global drama-a David to pharma's Goliaths-turning its te...